These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15119475)

  • 21. [Treatment-resistant anxiety disorders: A literature review of drug therapy strategies].
    Ammar G; Naja WJ; Pelissolo A
    Encephale; 2015 Jun; 41(3):260-5. PubMed ID: 25439852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mania in a case of polypsychopharmacology: pharmacodynamic and pharmacokinetic considerations. Do you believe in magic?
    Preskorn SH
    J Psychiatr Pract; 2007 May; 13(3):178-83. PubMed ID: 17522561
    [No Abstract]   [Full Text] [Related]  

  • 23. Side effects associated with psychoactive medication in individuals with autism.
    Aman MG; Van Bourgondien ME; Osborne PW; Sarphare G
    J Autism Dev Disord; 1997 Jun; 27(3):342-4. PubMed ID: 9229265
    [No Abstract]   [Full Text] [Related]  

  • 24. Strategies for pharmacologic treatment of high functioning autism and Asperger syndrome.
    Towbin KE
    Child Adolesc Psychiatr Clin N Am; 2003 Jan; 12(1):23-45. PubMed ID: 12512397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pediatric psychopharmacology of autism spectrum disorder: A systematic review - Part I: The past and the present.
    Persico AM; Ricciardello A; Lamberti M; Turriziani L; Cucinotta F; Brogna C; Vitiello B; Arango C
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Aug; 110():110326. PubMed ID: 33857522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurotropic and psychotropic drugs in dermatology.
    Tennyson H; Levine N
    Dermatol Clin; 2001 Jan; 19(1):179-97, x. PubMed ID: 11155582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted treatments for symptom domains in child and adolescent autism.
    Hollander E; Phillips AT; Yeh CC
    Lancet; 2003 Aug; 362(9385):732-4. PubMed ID: 12957098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AEDs and psychotropic drugs in children with autism and epilepsy.
    Tuchman R
    Ment Retard Dev Disabil Res Rev; 2004; 10(2):135-8. PubMed ID: 15362171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacotherapy for eating disorders and obesity.
    Powers PS; Bruty H
    Child Adolesc Psychiatr Clin N Am; 2009 Jan; 18(1):175-87. PubMed ID: 19014865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Children and autism--Part 1--recognition and pharmacological management.
    Angley M; Young R; Ellis D; Chan W; McKinnon R
    Aust Fam Physician; 2007 Sep; 36(9):741-4. PubMed ID: 17915375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treating functional impairment of autism with selective serotonin-reuptake inhibitors.
    Moore ML; Eichner SF; Jones JR
    Ann Pharmacother; 2004 Sep; 38(9):1515-9. PubMed ID: 15292500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pathophysiology, medical management, and dental implications of autism.
    Friedlander AH; Yagiela JA; Paterno VI; Mahler ME
    J Calif Dent Assoc; 2003 Sep; 31(9):681-2, 684, 686-91. PubMed ID: 14560872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacotherapeutic management of autism.
    Posey DJ; McDougle CJ
    Expert Opin Pharmacother; 2001 Apr; 2(4):587-600. PubMed ID: 11336609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders.
    Aman MG; Farmer CA; Hollway J; Arnold LE
    Child Adolesc Psychiatr Clin N Am; 2008 Oct; 17(4):713-38, vii. PubMed ID: 18775366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early pharmacological treatment of autism: a rationale for developmental treatment.
    Bethea TC; Sikich L
    Biol Psychiatry; 2007 Feb; 61(4):521-37. PubMed ID: 17276749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Psychopharmacology of autistic disorders].
    Poustka L; Poustka F
    Z Kinder Jugendpsychiatr Psychother; 2007 Mar; 35(2):87-94. PubMed ID: 17608278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychopharmacology in autism: an update.
    Canitano R; Scandurra V
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):18-28. PubMed ID: 21034789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychotropic and anticonvulsant drugs in subjects with autism: prevalence and patterns of use.
    Aman MG; Van Bourgondien ME; Wolford PL; Sarphare G
    J Am Acad Child Adolesc Psychiatry; 1995 Dec; 34(12):1672-81. PubMed ID: 8543539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enuresis with combined risperidone and SSRI use.
    Took KJ; Buck BJ
    J Am Acad Child Adolesc Psychiatry; 1996 Jul; 35(7):840-1. PubMed ID: 8768340
    [No Abstract]   [Full Text] [Related]  

  • 40. Diagnosis and treatment of autism spectrum disorders.
    Manning-Courtney P; Brown J; Molloy CA; Reinhold J; Murray D; Sorensen-Burnworth R; Messerschmidt T; Kent B
    Curr Probl Pediatr Adolesc Health Care; 2003 Oct; 33(9):283-304. PubMed ID: 14534514
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.